Drug Type Autologous CAR-T |
Synonyms |
Target |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | IND Application | CN | 30 Jan 2022 | |
Lymphoma | Preclinical | CN | 23 Aug 2024 | |
Multiple Sclerosis | Preclinical | CN | 23 Aug 2024 | |
Systemic Lupus Erythematosus | Preclinical | CN | 23 Aug 2024 |